Gyon Technologies Capital Management, LP Seres Therapeutics, Inc. Transaction History

Gyon Technologies Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$5.09 - $9.05 $18,838 - $33,494	-3,701 Reduced 29.04%	9,044 $50,000
Q3 2022 Nov 14, 2022	BUY	$3.5 - $7.2 $44,607 - $91,764	12,745 New	12,745 $82,000
Q1 2022 May 12, 2022	SELL	$6.3 - $8.84 $340,848 - $478,270	-54,103 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$6.02 - $11.43 $325,700 - $618,397	54,103 New	54,103 $451,000

46.3M

119K

466K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $114M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.